Rheum for Everyone, Episode 24 (video)| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Research Rheum

Rheumatology Research Foundation Advances Studies in Inflammatory Arthritis

Staff  |  October 1, 2013

Disease Targeted Research Initiative may improve treatment, prevention of rheumatoid arthritis, other inflammatory diseases

New Insights into CPPD

Robert Terkeltaub, MD  |  October 1, 2013

Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease

Lactoferricin’s Role in Preventing Disc Degeneration

Lara C. Pullen, PhD  |  September 16, 2013

The combination of bone-morphogenetic protein-7 (BMP7) and lactoferricin B (LfcinB) may be a useful treatment for disc degeneration. (posted Sept. 16, 2013)

Sensory Nerves May Be Key for Osteoporosis

Lara C. Pullen, PhD  |  September 10, 2013

Sensory nerves have an essential role in bone remodeling. In particular, semaphorin 3A (Sema3A) regulates bone remodeling by modulating sensory nerve development. (posted Sept. 9, 2013)

Rheumatology Research Foundation Announces 2013 Awards and Grants Recipients

Staff  |  September 1, 2013

The Foundation names winners of education and training awards, career development research awards, and disease-targeted research grants

ACR Research Conferences to Focus on Rheumatic Diseases

Staff  |  September 1, 2013

The ACR’s Basic Research Conference and Clinical Research Conference on October 25–26 to feature new perspectives on development of rheumatoid arthritis, lupus, and vasulitis, and review current thinking on preclinical rheumatic disease

EULAR 2013: Research Hints at Risk Factors for Rheumatoid Arthritis

Thomas R. Collins  |  September 1, 2013

Studies point to involvement of anti-CCP antibodies and citrullinated targets in the lungs and joints in the development of RA, and suggest an early therapeutic window for prevention

New Methodology to Improve Cartilage Repair

Lara C. Pullen, PhD  |  July 31, 2013

A single treatment with recombinant acid ceramidase improves the chondrogenic phenotype of primary chondrocytes and leads to an increased yield of mesenchymal stem cells.  (posted July 31, 2013)

B-Cell Genes Interact to Increase Risk for Rheumatoid Arthritis

Lara C. Pullen, PhD  |  July 31, 2013

Researchers demonstrate that BANK1 is a susceptibility gene for RA, and it may play a role in RA pathogenesis. (posted June 31, 2013)

Rheumatology Drug Research Should Focus on Particular Groups of Patients

Deborah Levenson  |  July 1, 2013

An analysis of risks and benefits of drugs in specific types of patients will help rheumatologists provide better treatment

  • « Previous Page
  • 1
  • …
  • 88
  • 89
  • 90
  • 91
  • 92
  • …
  • 128
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences